drugset / Trial / NCT00006773
Bortezomib in Treating Patients With Recurrent Glioma
NaSingle-groupOpen-labelTreatment
Summary
Phase I trial to study the effectiveness of bortezomib in treating patients who have recurrent glioma. Bortezomib may stop the growth of tumor cells by blocking the enzymes necessary for tumor cell growth
Timeline
- Start
- 2001-05
- Primary completion
- 2007-06
- Completion
- —
Outcome
Outcome not reported
Stopped: “Administratively complete.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bortezomib | Small molecule | — | Intravenous |